Cambridge Healthtech Institute Announces its Production & Manufacturing of Vaccines Conference

May 11, 2011 - PRLog -- Cambridge Healthtech Institute will hold its Third Annual Production & Manufacturing of Vaccines conference on August 16-17, 2011 at the Boston Marriott Cambridge Hotel in Cambridge, MA. This conference is part of ImVacS: The Immunotherapeutics & Vaccine Summit.

This event brings together experts from vaccine manufacturers, suppliers, quality control, and platform development to learn new technologies, network with colleagues and advance the field of vaccine and immunotherapeutic manufacturing. With the advent of new vaccines for both infectious disease and therapeutic use, the challenge for the vaccine manufacturer is to increase productivity, maintain adherence to regulatory requirements and evaluate novel platforms and technologies to stay current. In addition to the technological advances of the field, the increased importance of both U.S. and international regulatory agencies will be addressed as well as the latest in FDA guidance documents and their impact on current production.

Our speaker line-up includes internationally recognized experts: Rahul Singhvi, Sc.D., CEO & President, Novavax; Richard Schwartz, Ph.D., Chief, Vaccine Production Lab, NIH NIAID; Brigitte Barbeau, VP Manufacturing, Medicago R&D Inc., amongst many more.

This conference will bring you face to face with not only the eminent names mentioned above but also key scientists from Pharma, Biotech, CMOs, and academic and government institutes that will lead sessions on:

* Influenza Production
* Regulatory Considerations
* Autologous Vaccine Production
* Manufacturing Efficiencies

View the speaker line-up, agenda and register at: http://www.healthtech.com/imt/vpd or call 781-972-5400.

Those who register by May 13 will save up to $400 off the published rate.

Writers and editors are invited to attend.  To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (http://www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com
http://www.healthtech.com/imt/vpd